HBIO vs NSC · rev $22.7M vs P/E 18, rev $6.46B
Harvard Bioscience Inc (HBIO) versus Norfolk Southern Corporation (NSC) — a side-by-side from cached financials, not a winner call.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
HBIO currently screens at market cap $20.3M. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Not investment advice. Open the HBIO and NSC stock pages for the full models.
Not investment advice.